Browsing Tag


Sanofi to buy Synthorx for $2.5 billion

France’s Sanofi said on Monday it had agreed to buy Synthorx in a cash deal worth around $2.5 billion as it seeks to beef up its immuno-oncology pipeline.Under the terms of the merger agreement, Sanofi has offered to buy all of the